Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients
- 6 December 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 188 (1-2) , 115-119
- https://doi.org/10.1016/s0304-3835(01)00839-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesisProceedings of the National Academy of Sciences, 1999
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- High sensitivity mapping of methylated cytosinesNucleic Acids Research, 1994
- A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.Proceedings of the National Academy of Sciences, 1992
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Neoplastic Characteristics of the DNA Found in the Plasma of Cancer PatientsOncology, 1989
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Estimates of the worldwide frequency of sixteen major cancers in 1980International Journal of Cancer, 1988
- Prevalence of ras gene mutations in human colorectal cancersNature, 1987